Global Serialisation as a Service 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI02257976

Publication Date:

February 19, 2025

Pages:

138

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global Serialisation as a Service market size is predicted to grow from US$ 1286 million in 2025 to US$ 1752 million in 2031; it is expected to grow at a CAGR of 5.3% from 2025 to 2031.
Serialization as a Service is a flexible solution designed specifically for the pharmaceutical industry to meet the stringent requirements of regulatory agencies such as the European Union for anti-counterfeiting and traceability of pharmaceutical packaging. The service ensures that each product can be traced back to its manufacturer by providing each pharmaceutical package with a unique and traceable serial number and barcode. Given the complex laws and regulations and high equipment investment costs faced by the pharmaceutical industry, as well as the expertise required in the serialization process, Serialization as a Service provides a cost-effective and easy-to-integrate solution. Manufacturers do not need to bear the development and maintenance of serialization systems themselves, but can seamlessly integrate them into their own logistics chains, allowing them to focus on their core business while ensuring compliance and product quality.
United States market for Serialisation as a Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Serialisation as a Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Serialisation as a Service is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Serialisation as a Service players cover Aphena Pharma Solutions, NNE, Sharp Services, Movianto, UPM Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
The 鈥淪erialisation as a Service Industry Forecast鈥� looks at past sales and reviews total world Serialisation as a Service sales in 2024, providing a comprehensive analysis by region and market sector of projected Serialisation as a Service sales for 2025 through 2031. With Serialisation as a Service sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Serialisation as a Service industry.
This Insight Report provides a comprehensive analysis of the global Serialisation as a Service landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Serialisation as a Service portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Serialisation as a Service market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Serialisation as a Service and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Serialisation as a Service.
This report presents a comprehensive overview, market shares, and growth opportunities of Serialisation as a Service market by product type, application, key players and key regions and countries.
Segmentation by Type:
Barcode
QR Code
RFID
Others
Segmentation by Application:
Pharmaceutical Manufacturing
Pharmaceutical Distribution
Pharmaceutical Logistics
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Aphena Pharma Solutions
NNE
Sharp Services
Movianto
UPM Pharmaceuticals
MSK Pharmalogisti
Covectra
Koerber-Pharma
Palladio Group
TraceLink
Ultimate Solutions
Clarkston Consulting
Jones Healthcare Group
MSK Pharmalogistic
Vetter-Pharma
NextPharma Logistics
OPTEL
Central Pharma

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global Serialisation as a Service 麻豆原创 Size (2020-2031)
2.1.2 Serialisation as a Service 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Serialisation as a Service by Country/Region (2020, 2024 & 2031)
2.2 Serialisation as a Service Segment by Type
2.2.1 Barcode
2.2.2 QR Code
2.2.3 RFID
2.2.4 Others
2.3 Serialisation as a Service 麻豆原创 Size by Type
2.3.1 Serialisation as a Service 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Serialisation as a Service 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 Serialisation as a Service Segment by Application
2.4.1 Pharmaceutical Manufacturing
2.4.2 Pharmaceutical Distribution
2.4.3 Pharmaceutical Logistics
2.5 Serialisation as a Service 麻豆原创 Size by Application
2.5.1 Serialisation as a Service 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Serialisation as a Service 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 Serialisation as a Service 麻豆原创 Size by Player
3.1 Serialisation as a Service 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global Serialisation as a Service Revenue by Player (2020-2025)
3.1.2 Global Serialisation as a Service Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global Serialisation as a Service Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Serialisation as a Service by Region
4.1 Serialisation as a Service 麻豆原创 Size by Region (2020-2025)
4.2 Global Serialisation as a Service Annual Revenue by Country/Region (2020-2025)
4.3 Americas Serialisation as a Service 麻豆原创 Size Growth (2020-2025)
4.4 APAC Serialisation as a Service 麻豆原创 Size Growth (2020-2025)
4.5 Europe Serialisation as a Service 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa Serialisation as a Service 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas Serialisation as a Service 麻豆原创 Size by Country (2020-2025)
5.2 Americas Serialisation as a Service 麻豆原创 Size by Type (2020-2025)
5.3 Americas Serialisation as a Service 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Serialisation as a Service 麻豆原创 Size by Region (2020-2025)
6.2 APAC Serialisation as a Service 麻豆原创 Size by Type (2020-2025)
6.3 APAC Serialisation as a Service 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Serialisation as a Service 麻豆原创 Size by Country (2020-2025)
7.2 Europe Serialisation as a Service 麻豆原创 Size by Type (2020-2025)
7.3 Europe Serialisation as a Service 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Serialisation as a Service by Region (2020-2025)
8.2 Middle East & Africa Serialisation as a Service 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa Serialisation as a Service 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global Serialisation as a Service 麻豆原创 Forecast
10.1 Global Serialisation as a Service Forecast by Region (2026-2031)
10.1.1 Global Serialisation as a Service Forecast by Region (2026-2031)
10.1.2 Americas Serialisation as a Service Forecast
10.1.3 APAC Serialisation as a Service Forecast
10.1.4 Europe Serialisation as a Service Forecast
10.1.5 Middle East & Africa Serialisation as a Service Forecast
10.2 Americas Serialisation as a Service Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 Serialisation as a Service Forecast
10.2.2 Canada 麻豆原创 Serialisation as a Service Forecast
10.2.3 Mexico 麻豆原创 Serialisation as a Service Forecast
10.2.4 Brazil 麻豆原创 Serialisation as a Service Forecast
10.3 APAC Serialisation as a Service Forecast by Region (2026-2031)
10.3.1 China Serialisation as a Service 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 Serialisation as a Service Forecast
10.3.3 Korea 麻豆原创 Serialisation as a Service Forecast
10.3.4 Southeast Asia 麻豆原创 Serialisation as a Service Forecast
10.3.5 India 麻豆原创 Serialisation as a Service Forecast
10.3.6 Australia 麻豆原创 Serialisation as a Service Forecast
10.4 Europe Serialisation as a Service Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 Serialisation as a Service Forecast
10.4.2 France 麻豆原创 Serialisation as a Service Forecast
10.4.3 UK 麻豆原创 Serialisation as a Service Forecast
10.4.4 Italy 麻豆原创 Serialisation as a Service Forecast
10.4.5 Russia 麻豆原创 Serialisation as a Service Forecast
10.5 Middle East & Africa Serialisation as a Service Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 Serialisation as a Service Forecast
10.5.2 South Africa 麻豆原创 Serialisation as a Service Forecast
10.5.3 Israel 麻豆原创 Serialisation as a Service Forecast
10.5.4 Turkey 麻豆原创 Serialisation as a Service Forecast
10.6 Global Serialisation as a Service Forecast by Type (2026-2031)
10.7 Global Serialisation as a Service Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 Serialisation as a Service Forecast
11 Key Players Analysis
11.1 Aphena Pharma Solutions
11.1.1 Aphena Pharma Solutions Company Information
11.1.2 Aphena Pharma Solutions Serialisation as a Service Product Offered
11.1.3 Aphena Pharma Solutions Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Aphena Pharma Solutions Main Business Overview
11.1.5 Aphena Pharma Solutions Latest Developments
11.2 NNE
11.2.1 NNE Company Information
11.2.2 NNE Serialisation as a Service Product Offered
11.2.3 NNE Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 NNE Main Business Overview
11.2.5 NNE Latest Developments
11.3 Sharp Services
11.3.1 Sharp Services Company Information
11.3.2 Sharp Services Serialisation as a Service Product Offered
11.3.3 Sharp Services Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Sharp Services Main Business Overview
11.3.5 Sharp Services Latest Developments
11.4 Movianto
11.4.1 Movianto Company Information
11.4.2 Movianto Serialisation as a Service Product Offered
11.4.3 Movianto Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Movianto Main Business Overview
11.4.5 Movianto Latest Developments
11.5 UPM Pharmaceuticals
11.5.1 UPM Pharmaceuticals Company Information
11.5.2 UPM Pharmaceuticals Serialisation as a Service Product Offered
11.5.3 UPM Pharmaceuticals Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 UPM Pharmaceuticals Main Business Overview
11.5.5 UPM Pharmaceuticals Latest Developments
11.6 MSK Pharmalogisti
11.6.1 MSK Pharmalogisti Company Information
11.6.2 MSK Pharmalogisti Serialisation as a Service Product Offered
11.6.3 MSK Pharmalogisti Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 MSK Pharmalogisti Main Business Overview
11.6.5 MSK Pharmalogisti Latest Developments
11.7 Covectra
11.7.1 Covectra Company Information
11.7.2 Covectra Serialisation as a Service Product Offered
11.7.3 Covectra Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Covectra Main Business Overview
11.7.5 Covectra Latest Developments
11.8 Koerber-Pharma
11.8.1 Koerber-Pharma Company Information
11.8.2 Koerber-Pharma Serialisation as a Service Product Offered
11.8.3 Koerber-Pharma Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Koerber-Pharma Main Business Overview
11.8.5 Koerber-Pharma Latest Developments
11.9 Palladio Group
11.9.1 Palladio Group Company Information
11.9.2 Palladio Group Serialisation as a Service Product Offered
11.9.3 Palladio Group Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Palladio Group Main Business Overview
11.9.5 Palladio Group Latest Developments
11.10 TraceLink
11.10.1 TraceLink Company Information
11.10.2 TraceLink Serialisation as a Service Product Offered
11.10.3 TraceLink Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 TraceLink Main Business Overview
11.10.5 TraceLink Latest Developments
11.11 Ultimate Solutions
11.11.1 Ultimate Solutions Company Information
11.11.2 Ultimate Solutions Serialisation as a Service Product Offered
11.11.3 Ultimate Solutions Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 Ultimate Solutions Main Business Overview
11.11.5 Ultimate Solutions Latest Developments
11.12 Clarkston Consulting
11.12.1 Clarkston Consulting Company Information
11.12.2 Clarkston Consulting Serialisation as a Service Product Offered
11.12.3 Clarkston Consulting Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Clarkston Consulting Main Business Overview
11.12.5 Clarkston Consulting Latest Developments
11.13 Jones Healthcare Group
11.13.1 Jones Healthcare Group Company Information
11.13.2 Jones Healthcare Group Serialisation as a Service Product Offered
11.13.3 Jones Healthcare Group Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Jones Healthcare Group Main Business Overview
11.13.5 Jones Healthcare Group Latest Developments
11.14 MSK Pharmalogistic
11.14.1 MSK Pharmalogistic Company Information
11.14.2 MSK Pharmalogistic Serialisation as a Service Product Offered
11.14.3 MSK Pharmalogistic Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 MSK Pharmalogistic Main Business Overview
11.14.5 MSK Pharmalogistic Latest Developments
11.15 Vetter-Pharma
11.15.1 Vetter-Pharma Company Information
11.15.2 Vetter-Pharma Serialisation as a Service Product Offered
11.15.3 Vetter-Pharma Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Vetter-Pharma Main Business Overview
11.15.5 Vetter-Pharma Latest Developments
11.16 NextPharma Logistics
11.16.1 NextPharma Logistics Company Information
11.16.2 NextPharma Logistics Serialisation as a Service Product Offered
11.16.3 NextPharma Logistics Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 NextPharma Logistics Main Business Overview
11.16.5 NextPharma Logistics Latest Developments
11.17 OPTEL
11.17.1 OPTEL Company Information
11.17.2 OPTEL Serialisation as a Service Product Offered
11.17.3 OPTEL Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 OPTEL Main Business Overview
11.17.5 OPTEL Latest Developments
11.18 Central Pharma
11.18.1 Central Pharma Company Information
11.18.2 Central Pharma Serialisation as a Service Product Offered
11.18.3 Central Pharma Serialisation as a Service Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.18.4 Central Pharma Main Business Overview
11.18.5 Central Pharma Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.